Bioisosteric Discovery of NPA101.3, a Second-Generation RET/VEGFR2 Inhibitor Optimized for Single-Agent Polypharmacology.
Moccia M, Frett B, Zhang L, Lakkaniga NR, Briggs DC, Chauhan R, Brescia A, Federico G, Yan W, Santoro M, McDonald NQ, Li HY, Carlomagno F.
Moccia M, et al. Among authors: lakkaniga nr.
J Med Chem. 2020 May 14;63(9):4506-4516. doi: 10.1021/acs.jmedchem.9b01336. Epub 2020 Apr 28.
J Med Chem. 2020.
PMID: 32298114
Free PMC article.